NCT06163768

Brief Summary

Effects of insulin resistance in non-diabetic acute coronary syndrome patients by the homeostasis model assessment index (HOMA2-IR)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
8mo left

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Dec 2023Dec 2026

First Submitted

Initial submission to the registry

November 15, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

December 11, 2023

Completed
20 days until next milestone

Study Start

First participant enrolled

December 31, 2023

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

December 11, 2023

Status Verified

December 1, 2023

Enrollment Period

2.8 years

First QC Date

November 15, 2023

Last Update Submit

December 1, 2023

Conditions

Insulin Resistance

Outcome Measures

Primary Outcomes (1)

  • Model HOMA-IR

    Use SPSS software to analyze data

    January 2026

Study Arms (1)

insulin

OTHER

This is a prospective study, without intervention in the clinical treatment plan at the hospital

Procedure: Insulin resistance

Interventions

Insulin resistancePROCEDURE

Steps to conduct testing and treatment according to the approved regimen at Ho Chi Minh City University of Medicine and Pharmacy Hospital. The researcher did not intervene in the treatment process.

insulin

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may not qualify if:

  • Control group
  • Patients \< 18 years old.
  • History of heart disease or stroke
  • Exclude diabetic subjects
  • Exclude subjects at high risk of insulin resistance
  • Researchers
  • Have diabetes or have previously been diagnosed with diabetes.
  • Patients \< 18 years old.
  • The patient does not participate in follow-up examinations and does not follow up treatment at the medical facility.
  • The patient died before reaching the hospital.
  • Patients with severe medical diseases: cirrhosis, cancer, obstructive pulmonary disease chronic obstructive pulmonary disease, chronic heart failure, severe kidney failure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical and Pharmaceutical University Hospital

Ho Chi Minh City, Five, 70000, Vietnam

RECRUITING

MeSH Terms

Conditions

Insulin Resistance

Interventions

insulin resistance factor (uremia)

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Nguyen Ngoc Minh Thu

CONTACT

+84907484296nnmthu.ncs.khys.hoasinh23@ump.edu.vn

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
University of Medicine and Pharmacy at Ho Chi Minh City

Study Record Dates

First Submitted

November 15, 2023

First Posted

December 11, 2023

Study Start

December 31, 2023

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

December 11, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations

VN(1)